USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Analysis of the European HIV Drugs Market
Analysis of the European HIV Drugs Market
Increasing Adoption of Oral Combination-pills for Treatment Boosts Market Growth
RELEASE DATE
23-Jan-2013
23-Jan-2013
REGION
North America
North America
Research Code: M8EA-01-00-00-00
SKU: LS00092-NA-MR_16933
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
LS00092-NA-MR_16933
Description
This research service provides an in-depth analysis of the HIV drugs market across Europe. It analyses the revenue potential, market dynamics, trends, and the competitive structure. The revenue values of the European HIV drugs market have been derived from market sales and pipeline investment made under drug classes like nucleoside reverse transcriptase inhibitors, protease inhibitors, non-nucleoside reverse transcriptase inhibitors and integrase inhibitors. The market analysed in this research service has been approached from a manufacturer's point of view. Apart from segmentation by drug classes, the market has also been broken down based on major Western European countries.
Table of Contents
Executive Summary
Executive Summary—Market Engineering Measurements
Executive Summary—Market Engineering Measurements (continued)
Executive Summary—CEO’s Perspective
Market Overview—Scope of the Study
Market Overview—Definitions
Market Overview—Definitions (continued)
Market Overview—Key Questions This Study Will Answer
Market Overview—Segmentation based on Types of ARV Therapy
Market Overview—Segmentation based on Types of ARV Therapy (continued)
Market Overview—Segmentation based on Geography
Market Overview—Segmentation based on Geography (continued)
Drivers and Restraints
Drivers Explained
Drivers Explained (continued)
Drivers Explained (continued)
Restraints Explained
Restraints Explained (continued)
Restraints Explained (continued)
Impact Mapping of Drivers and Restraints
Market Engineering Measurements
Market Engineering Measurements (continued)
Forecast Assumptions
Total HIV Drugs Market—Revenue Forecast
Total HIV Drugs Market—Revenue Forecast by Segment
Revenue Forecast Discussion
Total HIV Drugs Market—Growth Analysis by Segment
Total HIV Drugs Market—Per cent Revenue Forecast by Region
Total HIV Drugs Market—Revenue Forecast by Region
Regional Revenue Forecast Discussion
HIV Drugs Market—Metrics Analysis
PEST Analysis
Competitive Analysis—Market Share
Market Share Analysis
Market Share Analysis (continued)
Competitive Environment
HIV Drugs Market—Competitive Landscape
Marketed Product Analysis
Marketed Product Analysis (continued)
Marketed Product Analysis (continued)
Key Pipeline Products by Segment
Key Pipeline Products by Segment (continued)
Key Pipeline Products by Segment (continued)
Key Pipeline Products by Segment (continued)
Key Pipeline Products—Analysis
NRTI Segment Overview
NRTI Segment—Market Engineering Measurements
NRTI Segment—Revenue Forecast
NRTI Segment—Revenue Forecast Discussion
NRTI Segment—Metrics Analysis
NRTI Segment—Impact of Key Market Trends
PI Segment Overview
PI Segment—Market Engineering Measurements
PI Segment—Revenue Forecast
PI Segment—Revenue Forecast Discussion
PI Segment—Metrics Analysis
PI Segment—Impact of Key Market Trends
NNRTI Segment Overview
NNRTI Segment—Market Engineering Measurements
NNRTI Segment—Revenue Forecast
NNRTI Segment—Revenue Forecast Discussion
NNRTI Segment—Metrics Analysis
NNRTI Segment—Impact of Key Market Trends
Integrase Inhibitor Segment Overview
Integrase Inhibitor Segment—Market Engineering Measurements
Integrase Inhibitor Segment—Revenue Forecast
Integrase Inhibitor Segment—Revenue Forecast Discussion
Integrase Inhibitor Segment—Metrics Analysis
Integrase Inhibitor Segment—Impact of Key Market Trends
Other Therapeutics Segment Overview
Other Therapeutics Segment—Market Engineering Measurements
Other Therapeutics Segment—Revenue Forecast
Other Therapeutics Segment—Revenue Forecast Discussion
The United Kingdom Market—Introduction
The United Kingdom Market—Market Engineering Measurements
The United Kingdom Market—Revenue Forecast
The United Kingdom Market—Revenue Forecast Discussion
The United Kingdom Market—Key Trends and Implications
Germany Market—Introduction
Germany Market—Market Engineering Measurements
Germany Market—Revenue Forecast
Germany Market—Revenue Forecast Discussion
Germany Market—Key Trends and Implications
France Market—Introduction
France Market—Market Engineering Measurements
France Market—Revenue Forecast
France Market—Revenue Forecast Discussion
France Market—Key Trends and Implications
Spain Market—Introduction
Spain Market—Market Engineering Measurements
Spain Market—Revenue Forecast
Spain Market—Revenue Forecast Discussion
Spain Market—Key Trends and Implications
Italy Market—Introduction
Italy Market—Market Engineering Measurements
Italy Market—Revenue Forecast
Italy Market—Revenue Forecast Discussion
Italy Market—Key Trends and Implications
Belgium Market—Introduction
The Netherlands Market—Introduction
Luxembourg Market—Introduction
Benelux Market—Market Engineering Measurements
Benelux Market—Revenue Forecast
Benelux Market—Revenue Forecast Discussion
Benelux Market—Key Trends and Implications
Denmark Market—Introduction
Norway Market—Introduction
Sweden Market—Introduction
Finland Market—Introduction
Scandinavia Market—Market Engineering Measurements
Scandinavia Market—Revenue Forecast
Scandinavia Market—Revenue Forecast Discussion
Scandinavia Market—Key Trends and Implications
Conclusions—European HIV Drugs Market
The Last Word—Three Big Predictions
Legal Disclaimer
Market Engineering Methodology
Database of Key Industry Participants
Additional Sources of Information
Prevalence of HIV
Incidence of AIDS
Mortality Due to AIDS
Popular Topics
Dyslipidemia exists in many forms and is prevalent in developed regions. Although many patients with moderately elevated lipids are well served by available therapies, there is a significant patient population for whom these therapies are inappropriate or inadequate, thereby prompting development of innovative therapies to fill the gaps. This research service includes comprehensive information on the market background, analyses of drug development, detailed product and pipeline analyses, detailed product profiles for key marketed/late-stage products, and a global overview. The research service also provides time-sensitive details such as new product launch timelines, PCSK9 Phase 3 programs, and patent expirations.
| No Index | Yes |
|---|---|
| Podcast | No |
| Author | Deepika Pramod Chopda |
| WIP Number | M8EA-01-00-00-00 |
| Is Prebook | No |